Akorn to acquire Hi-Tech for US$640mn

28 August 2013 - Deborah Wilkes

Archived

Akorn is set to pay US$640 million for Hi-Tech Pharmacal, and plans to use the company's manufacturing capabilities to expand its private-label OTC business.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: